Issue Title Abstract File
Vol 12, No 4 (2010) 25 noyabrya 2010 g. «AstraZeneka Rossiya» ob\"yavilapromezhutochnye rezul'taty issledovaniya EPICLIN Abstract
- -.
Vol 10, No 1 (2008) 8 let nadezhdy: novye dannye issledovaniya ATAS Abstract
- -.
Vol 17, No 1 (2015) A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian Abstract
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
Vol 17, No 3 (2015) Adenosquamous carcinoma of the colon: case report Abstract
Nefedova N.A., Kharlova O.A., Malkov P.G., Kharlov N.S., Danilova N.V.
Vol 19, No 4 (2017) Advisory Board dedicated to the treatment of patients with first-line therapy of follicular lymphoma Resolution Abstract
- -.
Vol 19, No 1 (2017) Advisory Board. Treatment of unfit patients with chronic lymphocytic leukemia. Resolution Abstract
- -.
Vol 9, No 2 (2007) Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy Abstract
Semiglazov V.F., Semiglazov V.V.
Vol 3, No 2 (2001) Ad\"yuvantnaya khimioterapiya raka molochnoy zhelezy: ot alkiliruyushchikh preparatov i antimetabolitov k antratsiklinam i taksonam Abstract
Voznyy E.K.
Vol 11, No 4 (2009) Ad\"yuvantnaya terapiyav lechenii gastrointestinal'nykh stromal'nykh opukholey Abstract
Nikulin M.P., Stilidi I.S.
Vol 10, No 1 (2008) Ad\"yuvantnoe lechenie raka tolstoy kishki Abstract
Artamonova E.V., Podregul'skiy K.E.
Vol 17, No 3 (2015) Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial Abstract
Soria J., Felip E., Cobo M., Lu S., Syrigos K., Lee K.H., Göker E., Georgoulias V., Li W., Isla D., Guclu S.Z., Morabito A., Min Y.J., Ardizzoni A., Gadgeel S.M., Wang B., Chand V.K., Goss G.D.
Vol 3, No 4 (2001) Aktivatory plazminogena urokinaznogo i tkanevogo tipov i ikh ingibitor pervogo tipa pri rake pishchevoda (predvaritel'nye rezul'taty) Abstract
Gershteyn E.S., Goncharov D.Y., Kushlinekiy N.E., Poddubnaya I.V.
Vol 12, No 4 (2010) Aktivnaya khirurgicheskaya taktikav sovremennom algoritme lecheniyarasprostranennogo raka yaichnika Abstract
Pokataev I.A., Stenina M.B., Tyulyandina A.S., Tyulyandin S.A.
Vol 2, No 1 (2000) Aktual'nye voprosy limfodissektsii u bol'nykh rakom grudnogo otdela pishchevoda Abstract
Davydov M.I., Stilidi I.S., Arzykulov D.A., Ter-Ovanesov M.D., Godzhamanov Y.G., Lagoshnyy A.T.
Vol 19, No 1 (2017) Albumin-bound paclitaxel in the treatment of metastatic breast cancer Abstract
Artamonova E.V.
Vol 16, No 2 (2014) Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives Abstract
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
Vol 12, No 1 (2010) Alimta (pemetreksed) v pervoylinii lecheniya disseminirovannogonemelkokletochnogo raka legkogo Abstract
Bychkov M.B., Bol'shakova S.A., Bychkov Y.M.
Vol 9, No 2 (2007) Ambulatornoe lechenie khronicheskogo limfoleykoza: doma i steny pomogayut v ramkakh mezhdunarodnogo meditsinskogo simpoziuma «Rekomenduy svobodu!» Abstract
- -.
Vol 12, No 4 (2010) Analiz bazovykh issledovaniy III fazy podtverzhdaetpreimushchestvo denosumaba pered standartnoy terapieyu bol'nykh s metastaticheskim porazheniem kostey Abstract
- -.
Vol 6, No 4 (2004) Analiz lecheniya onkoginekologicheskikh opukholey v Yakutii Abstract
Kipriyanova N.S., Afanas'eva L.N., Aksel' E.M., Poddubnaya I.V.
Vol 7, No 1 (2005) Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere Abstract
Chevardov N.I., Tolstykh L.V., Puzakov K.G., Potapov Y.N.
Vol 5, No 3 (2003) Analiz sostoyaniya onkoginekologicheskoy pomoshchi naseleniyu v Respublike Sakha (Yakutiya) Abstract
Aksel' E.M., Afanas'eva L.N., Kipriyanova N.S., Smetanina V.D., Poddubnaya I.V.
Vol 8, No 3 (2006) Analiz sostoyaniya onkoginekologicheskoy pomoshchi v navoiyskom regione (Respublika Uzbekistan) Abstract
Kudryavtsev I.Y., Kerimov R.A.
Vol 5, No 3 (2003) Analiz sostoyaniya onkologicheskoy pomoshchi v Respublike Sakha (Yakutiya) za 1991-2001 gg Abstract
Poddubnaya I.V., Aksel' E.M., Kipriyanova N.S.
Vol 10, No 2 (2008) ANAPLASTIChESKAYa KRUPNOKLETOChNAYa LIMFOMA VZROSLYKh:VLIYaNIE PROGNOSTIChESKIKh FAKTOROV NA TERAPIYu Abstract
Semenova A.A., Sorokin E.N., Poddubnaya I.V., Probatova N.A., Timofeeva O.L.
Vol 4, No 1 (2002) Anastrozol kak perspektiva ad\"yuvantnogo lecheniya raka molochnoy zhelezy u bol'nykh v menopauze Abstract
Gorbunova V.A.
Vol 12, No 3 (2010) Anemiya i sposoby ee korrektsiiu onkologicheskikh bol'nykh Abstract
Babicheva L.G., Poddubnaya I.V.
Vol 4, No 3 (2002) Anemiya pri zlokachestvennykh opukholyakh Abstract
Breder V.V., Gorbunova V.A., Besova N.S.
Vol 13, No 2 (2011) Anemiya pri zlokachestvennykhnovoobrazovaniyakh: printsipy terapii Abstract
Gorokhovskaya G.N., Petina M.M.
Vol 16, No 2 (2014) Angiogenesis as a target for cancer therapy Abstract
Imyanitov E.N.
Vol 15, No 3 (2013) Antiangiogennaya terapiya disseminirovannogo kolorektal'nogo raka Abstract
Meshcheryakov A.A.
Vol 2, No 1 (2000) Antiemetogennaya terapiya ondasetronom pri polikhimioterapii zlokachestvennykh opukholey u devochek Abstract
Safonova S.A., Punanov Y.A., Kolygin B.A.
Vol 9, No 1 (2007) Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy? Abstract
Ptushkin V.V.
Vol 19, No 1 (2017) Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers Abstract
Stilidi I.S., Kotyukova A.Y., Lyadov V.K.
Vol 2, No 1 (2000) Arimideks - novyy nesteroidnyy selektivnyy ingibitor aromatazy Predvaritel'nye rezul'taty "Otkrytogo nesravnitel'nogo issledovaniya po otsenke effektivnosti i perenosimosti arimideksa ( 1 mg) pri lechenii rasprostranennogo raka molochnoy zhelezy u zhenshchin Abstract
Gorbunova V.A., Gorin A.M., Odintsov S.V., Kozlov D.V., Vychkov M.V., Dobrovol'skaya N.Y., Vazin I.G., Meshcheryakov A.A.
Vol 5, No 4 (2003) Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy Abstract
Semiglazov V.F., Zhil'tsova E.K., Semiglazov V.V., Ivanov V.G., Dashyan G.A., Klettsel' A.A., Bozhok A.A., Nurgaziev K.S., Topuzov E.E., Krivorot'ko P.V., Tsyrlina E.V., Bershteyn L.M.
Vol 3, No 4 (2001) Arimideks: novye vozmozhnosti v lechenii generalizovannogo raka molochnoy zhelezy Abstract
Borisov V.I.
Vol 7, No 2 (2005) Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy Abstract
Makarenko N.P.
Vol 11, No 4 (2009) Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy Abstract
Artamonova E.V.
Vol 7, No 3 (2005) Aromazin: printsip deystviya Abstract
Imyanitov E.N.
Vol 10, No 2 (2008) ASCO Innovatsionnye metody bor'by s onkologicheskimi zabolevaniyam Abstract
- -.
Vol 12, No 3 (2010) Astenicheskie rasstroystva,assotsiirovannye s khimioterapieyzlokachestvennykh novoobrazovaniy(Obzor literatury) Abstract
Shafigullin M.R., Ivanov S.V., Gorbunova V.A., Meshcheryakov A.A.
Vol 18, No 3 (2016) AstraZeneca Satellite Symposium “Light up and never fade away” Abstract
- -.
Vol 7, No 2 (2005) Astrotsitomy nizkoy stepeni zlokachestvennosti polushariy bol'shogo mozga Abstract
Aleshin V.A., Karakhan V.B.
Vol 17, No 3 (2015) Atsellbiya® - opyt primeneniya pervogo bioanaloga rituksimaba v rutinnoy praktike klinitsista Abstract
- -.
Vol 18, No 5 (2016) Autologous stem cells transplantation in the first remission of follicular lymphoma as "rescue therapy" in patients with unfavorable prognosis factors. The first prospective study results Abstract
Nesterova E.S., Kravchenko S.K., Baryakh E.A., Misyurina A.E., Mangasarova Y.K., Vorobev V.I., Chernova N.G., Gemdzhian E.G., Savchenko V.G.
Vol 16, No 3 (2014) Avastin in clinical chemotherapy of malignant tumors Abstract
Gorbunova V.A.
Vol 19, No 3 (2017) BCD-100 - first russian PD-1 inhibitor Abstract
Tyulyandin S.A., Fedyanin M.Y., Semiglazova T.Y., Moiseenko V.M., Odintsova S.V., Alekseev B.Y., Ivanov R.A., Shustova M.S.
Vol 16, No 3 (2014) Bevacizumab in advanced ovarian cancer: when, what for and why? Abstract
Tjulandina A.S.
Vol 11, No 1 (2009) Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO) Abstract
Zhukova L.G.
Vol 12, No 1 (2010) Bevatsizumab pri metastaticheskomi retsidiviruyushchem rake molochnoy zhelezy:metaanaliz randomizirovannykh issledovaniy Abstract
Kolyadina I.V., Poddubnaya I.V.
Vol 15, No 3 (2013) Bevatsizumab v kombinatsii s khimioluchevoy terapiey u bol'nykh glioblastomoy Abstract
Smolin A.V., Konev A.V., Kobyakov G.L., Nikolaeva S.N., Shamanskaya Y.E., Gorbunov A.V.
Vol 15, No 3 (2013) Bevatsizumab v kombinatsii s khimioterapiey pri rake molochnoy zhelezy Abstract
Manzyuk L.V., Kovalenko E.I., Artamonova E.V., Osmanova L.I.
Vol 12, No 3 (2010) Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti Abstract
Zhukova L.G.
Vol 12, No 3 (2010) Bezopasnost' ibandronovoy kislotypri dlitel'nom primenenii Abstract
Semenov N.N.
Vol 18, No 2 (2016) Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study Abstract
Ignatova E.O., Burdaeva O.N., Kopp M.V., Kotiv B.N., Udovitsa D.P., Stroiakovskii D.L., Alekseev S.M., Sheveleva L.P., Khorinko A.V., Shapovalova I.S., Moiseenko V.M., Ivanov R.A.
Vol 7, No 2 (2005) Biologicheskie kharakteristiki opukholi (proliferativnaya aktivnost', ploidnost' i steroidnye retseptory) i ikh vliyanie na neposredstvennye i otdalennye rezul'taty lecheniya zapushchennogo raka molochnoy zhelezy Abstract
Nikolaeva T.G., Vyshinskaya G.V., Rotobel'skaya L.E.
Vol 10, No 3 (2008) Bondronat v forme dlya priema vnutr' effektiven u bol'nykh s kostnymi metastazami raka molochnoy zhelezy. Opyt odnogo tsentra Abstract
Semenov N.N., Lichinitser M.R., Vyshinskaya G.V., Meshcheryakov A.A., Novikov V.V., Gutorov S.L., Borisova E.I., Nakhalova T.A., Mikhina Z.P., Lyubimova N.V., Chaklina E.A., Aplevich N.N.
Vol 15, No 4 (2013) Bone mineral density in patient with breast cancer Abstract
Poddubnaya I.V., Kizhaev E.V., Kolyadina I.V., Banov S.M., Zhmaeva E.M., Secko M.A.
Vol 19, No 2 (2017) Brachytherapy with ultrasound assistance in patients with cervical cancer Abstract
Kizhaev Y.E., Razumova E.L., Bessolova O.V.
Vol 17, No 2 (2015) Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy Abstract
Artamonova E.V., Manziuk L.V.
Vol 18, No 1 (2016) BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia) Abstract
Khokhlova S.V., Gorbunova V.A., Lyubchenko L.N., Imyanitov E.N.
Vol 17, No 1 (2015) Breast cancer immunology: theory and prospects (review) Abstract
Kolyadina I.V., Poddubnaya I.V.
Vol 15, No 2 (2013) Breast cancer: from guidelines to personalized oncology Abstract
PierFranco C., Valentina G.
Vol 18, No 2 (2016) Brentuximab vedotin in the treatment of relapsed and refractory forms of Hodgkin lymphoma Abstract
Demina E.A.
Vol 15, No 4 (2013) Brest cancer: international online cooperation on sharing experience Abstract
- -.
Vol 2, No 3 (2000) Bronkhoskopiya v diagnostike i lechenii opukholey trakheobronkhial'nogo stvola Abstract
Poddubnyy B.K., Ungiadze G.V., Belousova N.V., Polotskiy B.E., Kontsevaya A.Y., Alekseeva T.R., Kondrat'eva T.T.
Vol 18, No 5 (2016) Characteristics of approach to the treatment of chronic pain in terminal cancer patients Abstract
Nevzorova D.V., Ibragimov A.N., Bakunina E.A.
Vol 17, No 3 (2015) Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review) Abstract
Fedyanin M.I.
Vol 18, No 3 (2016) Circulating tumor cell: biology, methods of isolation, clinical significance in breast cancer Abstract
Nenahova Y.N., Lyadov V.K., Poddubnaya I.V.
Vol 17, No 3 (2015) Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer Abstract
Knyazev R.I., Poddubnaya I.V., Bokin I.I., Barinov V.V.
Vol 19, No 4 (2017) Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0 Abstract
Pavlikova O.A., Poddubnaya I.V., Kolyadina I.V., Abdullaev A.G., Komov D.V., Danzanova T.Y., Sinyukova G.T., Kozlov N.A., Ganshina I.P., Zhukova L.G., Aliyeva G.S., Kerimov R.A., Gordeeva O.O.
Vol 16, No 4 (2014) Clinical case long-term care of the patient with mCRPC Abstract
Zaborskiy I.N., Karjakin O.B.
Vol 19, No 4 (2017) Clinical cases of the treatment of metastatic colorectal cancer in Russia Abstract
Goldberg V.E., Hasanova A.I., Shkuratova V.V., Belevich Y.V., Popova N.O., Simolina E.I., Vysockaya V.V., Dudnikova E.A., Kravchuk T.L., Minnabetdinova R.R., Nekrasova O.V.
Vol 16, No 1 (2014) Clinical cases of treatment of hepatocellular carcinoma Abstract
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
Vol 20, No 1 (2018) Clinical cases of treatment of patients with advanced hepatocellular carcinoma Abstract
Petkau V.V., Gladkov O.A., Filatov P.N., Raigorodskii M.V., Tarkhanov A.A., Klimushkin A.V., Nikitina L.Y.
Vol 15, No 4 (2013) Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney Abstract
Klimenko A.A., Ivanov S.A.
Vol 16, No 3 (2014) Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer Abstract
Gridneva Y.V., Matveev V.B., Kupchan D.Z., Kalinin S.A., Peters M.V.
Vol 18, No 5 (2016) Clinical features and therapy of double-hit and double-expressor lymphomas Abstract
Baryakh E.A., Misyurina A.E., Kovrigina A.M., Obukhova T.N., Kravchenko S.K., Magomedova A.U., Zingerman B.V., Misyurina E.N., Poteshkina N.G., Lysenko M.A., Vorobev A.I.
Vol 20, No 1 (2018) Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia Abstract
Mirolyubova Y.V., Stadnik E.A.
Vol 18, No 3 (2016) Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene Abstract
Ryazhenov V.V., Gorokhova S.G.
Vol 19, No 2 (2017) Clinico-morphological predictors and treatment outcomes in cervical stump cancer Abstract
Usmanova L.S., Kuznetsov V.V., Mustafina E.A., Barinov V.V., Bokin I.I., Knyazev R.I., Akhmedova M.D.
Vol 15, No 1 (2013) Combined and complex treatment options for patients with operable rectal cancer Abstract
Barsukov Y.A., Tkachev S.I., Mamedli Z.Z., Kuzmichev D.V., Aliev В.А., Kim D.F.
Vol 17, No 4 (2015) Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas Abstract
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
Vol 18, No 1 (2016) Concerning selective neck dissections in oral squamous cell carcinoma Abstract
Alymov Y.V., Podvyaznikov S.O., Mudunov A.M.
Vol 19, No 4 (2017) Contemporary follicular lymphoma treatment approaches and the significance of BENEFIT study results Abstract
Babicheva L.G., Poddubnaya I.V.
Vol 20, No 1 (2018) Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin Abstract
Kolbin A.S., Mosikyan A.A., Balykina Y.E., Proskurin M.A.
Vol 18, No 2 (2016) Cost-effectiveness of empegfilgrastim (Extimia®) for the prevention of severe neutropenia in patients with malignant neoplasm of female breast Abstract
Rudakova A.V., Tolkacheva D.G., Gavrilova O.N., Vaganov A.S.
Vol 15, No 1 (2013) CUP-syndrome: the present view of the problem (a review of literature) Abstract
Levitskaya N.V., Lewitzki V., Komarov I.G., Nemtsova M.V., Poddubnaya I.V.
Vol 16, No 3 (2014) Current algorhytm of screening and early diagnosis of hepatocellular carcinoma Abstract
Tikhonov I.N., Pavlov C.S., Mayevskaya M.V., Ivashkin V.T.
Vol 15, No 1 (2013) Current approach to adjuvant therapy for breast cancer (a review) Abstract
Conte P., Guarneri V.
Vol 17, No 4 (2015) Current possibilities in diagnosis and treatment of diffuse large B cell lymphoma in children and adolescents: results of Pediatric Hematology and Oncology Research Institute of N.N.Blokhin Russian Cancer Research Center, international experience Abstract
Levashov A.S., Kovrigina A.M., Valiev T.T., Belyaeva E.S., Popa A.V., Mentkevich G.L.
Vol 18, No 5 (2016) Current treatment of chronic lymphocytic leukemia. New opportunities and new difficulties Abstract
Samoylova O.S.
Vol 17, No 3 (2015) Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer Abstract
Knyazev R.I., Poddubnaya I.V., Barinov V.V., Bokin I.I.
Vol 11, No 4 (2009) Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade Abstract
Lichinitser M.R., Semenov N.N.
Vol 17, No 2 (2015) Dental prevention of complications of chemotherapy hematologic diseases in children Abstract
Lutskaya I.K., Andreyeva V.A., Zinovenko O.G.
Vol 20, No 1 (2018) Dermatomyositis and polymyositis in breast cancer patients: a case reports Abstract
Ganshina I.P., Zhukova L.G., Burnevitch E.Z., Gordeeva O.O., Kondratieva O.E.
Vol 18, No 2 (2016) Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype Abstract
Karabina E.V., Zhukova L.G.
Vol 17, No 3 (2015) Diagnosis and treatment of diffuse large B cell lymphoma in children and adults (review of literature) Abstract
Levashov A.S., Valiev T.T., Kovrigina A.M., Popa A.V., Mentkevich G.L.
Vol 19, No 3 (2017) Diagnosis and treatment of malignant trophoblastic tumors: errors, dangers, complications (review of the literature) Abstract
Gasanbekova Z.A., Aliev S.A., Meshcheryakova L.A., Kozachenko V.P., Kuznetsov V.V.
1 - 100 of 831 Items 1 2 3 4 5 6 7 8 9 > >> 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies